5980 HORTON STREET, EMERYVILLE, CA
Financial Results, Press Release
Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors
Appoints Mayo Pujols as Chief Technology Officer
Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference
Announces Pricing of $100 Million Public Offering of Common Stock
Investor Presentation
Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Free Writing Prospectus
SEC Staff Correspondence
Correspondence
Submission Upload
Deregistration Letter